Valeant investor sues over Biovail deal; Italy plans cuts to generic-drug prices;

 @FiercePharma: With Aspen circling, Sigma gets piecemeal bids. Article | Follow @FiercePharma

> Valeant Pharmaceuticals' $3.2 million merger with Biovail shortchanges Valeant investors while enriching the company's executives, a shareholder said in a lawsuit. Story

> From next year, the maximum reimbursement paid for generic drugs by the Italian health service (SSN) will be based on the drugs' average prices in Europe, a move the government says will save around €600 million. Article

> Biogen Idec said its profit more than doubled in the second quarter compared to a year ago, when it entered a partnership on a potential multiple sclerosis drug. Report

> Australian vaccine maker CSL says its new $235 million plant will advance development of its portfolio of biotech cancer drugs, anti-infectives and plasma products. Report

> Europe's largest biotech company, Actelion (ATLN.VX), raised its 2010 earnings goal and posted stronger-than-expected sales of key heart and lung drug Tracleer. News

> Shares of King Pharmaceuticals rose Monday after a Goldman Sachs analyst upgraded the drug developer, citing an improved risk-reward profile. Article

> Shares of Perrigo fell Monday after a Goldman Sachs analyst downgraded the over-the-counter drug maker, saying the stock has become expensive. Story

> Emergent BioSolutions says additional biomanufacturing space at its Baltimore, MD, plant could help reduce expenditure through use of new timesaving manufacturing tech. Story

Biotech News

 @FierceBiotech: Ramius looks to buy out Cypress. Article | Follow @FierceBiotech

> Actelion gets option to buy Trophos for up to $250 million. Story

> FDA accepts Mannkind's response, sets PDUFA date. News

> Ireland mulls $6B biopharma center. Report

 Biotech Research News

> Researchers combat aging as a "stem cell disease." News

> Scotland looks to beef up life sciences sector. Report

> iPSC use may be limited by 'memory'. Item

> Merck R&D site closure a blow to Canada. Story

> Researchers plan to use iPS cells to combat Parkinson's. Article

Manufacturing News

> Laid off McNeil plant workers can bid for other J&J jobs. Story

> Stability tests prompt Bausch & Lomb ReNu recall. Article

> UK regulator sounds cold chain alarm. Item

And Finally... WHO's emergency committee may convene next week to determine whether the H1N1 flu pandemic is ending. Report